Colinz Laboratories Ltd has informed the Bombay Stock Exchange that it is exempt from submitting Related Party Transaction disclosures for the quarter ended June 30, 2026. The company is claiming this exemption based on Regulation 15(2)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation allows specific companies to be exempt from certain corporate governance and disclosure requirements.

Due to this exemption, the compliance with provisions specified in Regulation 17 to 27 and Clauses (b) to (i) [and (t)] of sub-regulation (2) of regulation 46 and para C, D and E of Schedule V of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 is not applicable to the company. Consequently, the company is not required to submit the Related Party Transaction disclosures as required under Regulation 23(9) of the SEBI (LODR) Regulations, 2015 for the stated period.

The disclosure was submitted to the exchange on July 3, 2026, by Vijaya Mani, Director of Colinz Laboratories Limited. The company’s Corporate Office is located at A/101, Pratik Estate, Next to Fortis Hospital, Mulund Link Road, Mumbai.

Key Details

Colinz Laboratories has concluded the sale of its factory undertaking located in Nashik for an aggregate consideration of Rs 4 Cr. The company received the second and final tranche of the payment on June 18, 2026, finalizing the transaction which included the factory building, machinery, and land situated at Plot No 60, STICE, Sinnar-Shirdi Road, Sinnar, Nashik-422112. The sale was executed to M/s. Hilsun Foods And Drugs Private Limited, an unrelated third party, ensuring the transaction was conducted at arm's length and falls outside the scope of a related party transaction.

Transaction Details

The agreement for the sale involved an MOU cum deed of assignment executed on January 26, followed by the Assignment of Leasehold Rights on June 18, 2026. The completion of the sale and disposal was officially recorded on June 18, 2026. The buyer, Hilsun Foods And Drugs Private Limited, holds its registered office at C-103, Rameshwar, Neelkanth Heights, Pokhran Road No. 2, Thane West - 400606, and is not part of the promoter or promoter group of Colinz Laboratories.

Regulatory Disclosures

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that the transaction is outside a Scheme of Arrangement and does not constitute a slump sale. Consequently, specific disclosures regarding amalgamation or merger were not applicable to this disposal of immovable property.